Current staging of renal cell carcinoma

Bradley C. Leibovich, Allan J. Pantuck, Matthew H.T. Bui, Ken Ryu-Han, Amnon Zisman, Robert Figlin, Arie Belldegrun

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Most (>80%) cancers involving the kidney are renal cell carcinoma (RCC). One third of patients diagnosed with kidney cancer have evidence of metastatic disease at the time of diagnosis, and as many as half of patients treated for localized disease eventually relapse. As is true for any other malignancy, one must determine which tumor features, patient factors, and laboratory techniques will provide diagnostic and prognostic information for patients with RCC. This article focuses on the history and rationale of the current staging systems for RCC as well as the potential for improvements by the addition of other clinical, pathologic, and molecular prognostic markers.

Original languageEnglish (US)
Pages (from-to)481-497
Number of pages17
JournalUrologic Clinics of North America
Volume30
Issue number3
DOIs
StatePublished - Aug 2003

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Current staging of renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Leibovich, B. C., Pantuck, A. J., Bui, M. H. T., Ryu-Han, K., Zisman, A., Figlin, R., & Belldegrun, A. (2003). Current staging of renal cell carcinoma. Urologic Clinics of North America, 30(3), 481-497. https://doi.org/10.1016/S0094-0143(03)00029-6